Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	313.24	292.09	415.52	546.09	246.55	398.7
Cash & Short-Term Investments	313.24	292.09	415.52	546.09	246.55	398.7
Cash Growth	11.89%	-29.70%	-23.91%	121.50%	-38.16%	12.55%
Accounts Receivable	187.08	101.34	117.29	98.13	94.5	52.04
Other Receivables	-	17.48	23.74	20.25	9.76	11.88
Receivables	187.08	118.82	141.04	118.37	104.26	63.91
Inventory	227.92	248.46	227.41	141.6	106.57	77.59
Prepaid Expenses	-	28.85	29.11	20.34	10.14	7.34
Total Current Assets	728.23	688.21	813.08	826.41	467.51	547.53
Property, Plant & Equipment	214.25	213.88	149.04	97.55	47.58	26.3
Long-Term Investments	-	0.63	0.9	0.58	0.41	1.16
Goodwill	646.78	610.06	682.48	591.39	625.32	460.23
Other Intangible Assets	38.7	39.61	48.7	30.46	8.49	8.66
Long-Term Deferred Tax Assets	-	21.04	32.45	50.71	39.27	42.17
Long-Term Deferred Charges	919.89	800.68	676.09	598.51	544.51	456.55
Total Assets	2,589	2,374	2,403	2,196	1,733	1,543

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	-	31.5	39.45	36.05	38.47	21.45
Accrued Expenses	-	47.54	85.08	68.94	52.65	46.96
Current Portion of Leases	11.85	11.56	10.92	10.27	5.55	4.2
Current Income Taxes Payable	-	6.62	11.93	11.87	1.28	0.3
Current Unearned Revenue	-	11.62	13.47	3.69	3.17	3.01
Other Current Liabilities	174.19	10.53	16.67	3.66	33.77	28.6
Total Current Liabilities	186.03	119.38	177.51	134.49	134.9	104.52
Long-Term Debt	108.77	83.27	-	-	-	-
Long-Term Leases	-	29.89	23.13	21.17	4.46	1.52
Long-Term Deferred Tax Liabilities	-	26.24	27.85	29.29	25.77	25.08
Other Long-Term Liabilities	28.23	1.87	17.48	65.62	137.83	126.02
Total Liabilities	323.02	260.65	245.97	250.57	302.95	257.15

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.82	0.82	0.81	0.81	0.76	0.75
Additional Paid-In Capital	1,798	1,785	1,772	1,764	1,314	1,253
Retained Earnings	414.1	316.91	291.76	119.57	27.75	9.28
Comprehensive Income & Other	52.35	10.65	92.19	60.89	87.78	22.09
Shareholders' Equity	2,266	2,113	2,157	1,945	1,430	1,285
Total Liabilities & Equity	2,589	2,374	2,403	2,196	1,733	1,543

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	120.61	124.72	34.04	31.44	10.01	5.72
Net Cash (Debt)	192.63	167.37	381.48	514.65	236.54	392.98
Net Cash Growth	23.94%	-56.13%	-25.88%	117.58%	-39.81%	13.24%
Net Cash Per Share	6.10	5.30	12.05	17.19	8.01	13.58
Filing Date Shares Outstanding	31.5	31.5	31.5	31.5	29.83	29.5
Total Common Shares Outstanding	31.5	31.5	31.5	31.5	29.83	29.5
Working Capital	542.2	568.83	635.57	691.92	332.61	443.01
Book Value Per Share	71.93	67.10	68.47	61.75	47.94	43.58
Tangible Book Value	1,580	1,464	1,426	1,323	796.33	816.56
Tangible Book Value Per Share	50.17	46.47	45.26	42.01	26.69	27.68
Machinery	-	307.41	217.57	153.61	98.52	68.04

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error